SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. Razzaque Ahmed, Shawn Shetty, A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab, Autoimmunity Reviews, 2015, 14, 4, 323

    CrossRef

  2. 2
    K.T. Amber, M. Hertl, An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab, Journal of the European Academy of Dermatology and Venereology, 2015, 29, 4
  3. 3
    A. Razzaque Ahmed, Shawn Shetty, The Emerging Role of Rituximab in Autoimmune Blistering Diseases, American Journal of Clinical Dermatology, 2015, 16, 3, 167

    CrossRef

  4. 4
    A.J. Kanwar, K. Vinay, G.U. Sawatkar, S. Dogra, R.W. Minz, N.H. Shear, H. Koga, N. Ishii, T. Hashimoto, Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study , British Journal of Dermatology, 2014, 170, 6
  5. 5
    H.H. Cho, S.-P. Jin, J. H. Chung, Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities, Journal of the European Academy of Dermatology and Venereology, 2014, 28, 2
  6. 6
    Keshavamurthy Vinay, Amrinder J. Kanwar, Gitesh U. Sawatkar, Sunil Dogra, Norito Ishii, Takashi Hashimoto, Successful use of rituximab in the treatment of childhood and juvenile pemphigus, Journal of the American Academy of Dermatology, 2014, 71, 4, 669

    CrossRef

  7. 7
    Shawn Shetty, A. R. Ahmed, Preliminary analysis of mortality associated with rituximab use in autoimmune diseases, Autoimmunity, 2013, 46, 8, 487

    CrossRef

  8. 8
    Francesco Caso, Luca Iaccarino, Silvano Bettio, Francesca Ometto, Luisa Costa, Leonardo Punzi, Andrea Doria, Refractory pemphigus foliaceus and Behçet’s disease successfully treated with tocilizumab, Immunologic Research, 2013, 56, 2-3, 390

    CrossRef

  9. 9
    Rituximab, Reactions Weekly, 2013, 1452, 1, 37

    CrossRef

  10. 10
    Haruna Matsuda-Hirose, Kazushi Ishikawa, Mizuki Goto, Yutaka Hatano, Sakuhei Fujiwara, Selective Elevation of Antibodies to Desmoglein 1 during the Transition from Mucocutaneous to Cutaneous Type Pemphigus Vulgaris, Annals of Dermatology, 2013, 25, 2, 263

    CrossRef

  11. 11
    Labib R. Zakka, Shawn S. Shetty, A. Razzaque Ahmed, Rituximab in the Treatment of Pemphigus Vulgaris, Dermatology and Therapy, 2012, 2, 1

    CrossRef